Regencell Bioscience Holdings (Regencell Bioscience Holdings) Change In Payables And Accrued Expense : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Change In Payables And Accrued Expense?

Regencell Bioscience Holdings's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was $0.00 Mil. It means Regencell Bioscience Holdings's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Jun. 2023 .

Regencell Bioscience Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2023 was $0.00 Mil. It means Regencell Bioscience Holdings's Accounts Payable & Accrued Expense increased by $0.00 Mil from Jun. 2022 to Jun. 2023 .

Regencell Bioscience Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Regencell Bioscience Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Change In Payables And Accrued Expense Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Payables And Accrued Expense

0.10

0.56

-0.49

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial				0.61	-	-	-	-

Regencell Bioscience Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Regencell Bioscience Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.